Clinical trial
Dose Reduction and Discontinuation of Prednisolone Using Structured Treat-to-target Taper in Patients With Polymyalgia Rheumatica
NCT05636501 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose Reduction and Discontinuation of Prednisolone Using Structured Treat-to-target Taper in Patients With Polymyalgia Rheumatica
- Lead sponsor
- Aarhus University Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 12, 2023
- Completion date
- November 30, 2026
- Enrollment
- 120 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.